According to a newly published market research report by 24LifeSciences, global biomonitoring and bioburden testing market was valued at USD 3.5 billion in 2024 and is projected to reach USD 6.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.2% during the forecast period 2025-2031.
Biomonitoring involves the measurement of toxic substances in biological specimens, while...
Healthcare infrastructure is expanding rapidly in many regions as governments and private organizations invest in advanced medical facilities. New hospitals, diagnostic centers, and specialized treatment facilities require a wide range of medical devices to provide effective patient care. Each of these devices must undergo testing before being introduced into healthcare environments.
The...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek